Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapiesAnn Nucl Med - Hartung-Knemeyer, V; Nagarajah, J; Jentzen, W (2012)
doi:10.1007/s12149–012–0632–1.